Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Traditional and Novel Migraine Therapy in the Aging Population.

Literature DB >> 31079259

Traditional and Novel Migraine Therapy in the Aging Population.

Abstract

Migraine is a common disabling disorder that affects 36 million Americans. The clinical features of migraine are less typical in the people above age 60, making the diagnosis and treatment difficult in this group. In this review, we will discuss migraine-specific drugs and their use in populations about age 60 who suffer from migraine. This discussion will include an overview of traditional treatments for the acute and preventive treatment of migraine, and considerations for their use in patient populations above age 60. In addition, we will discuss newer agents that show a more promising safety profile.

Entities: Disease Species

Keywords: Aging population; Ditan; Gepant; Migraine; Triptan

Mesh：

Substances：

Year: 2019 PMID： 31079259 DOI： 10.1007/s11916-019-0789-6

Source DB: PubMed Journal: Curr Pain Headache Rep ISSN： 1534-3081

55 in total

1. Epidemiological data relevant to prognosis in migraine in adults.

Authors: W E Waters
Journal: Dan Med Bull Date: 1975-03

Review 2. The management of persistent pain in older persons.

Authors:
Journal: J Am Geriatr Soc Date: 2002-06 Impact factor: 5.562

3. Effect of serotonin in migraine patients.

Authors: R W KIMBALL; A P FRIEDMAN; E VALLEJO
Journal: Neurology Date: 1960-02 Impact factor: 9.910

4. The prevalence of migraine in women aged 40-74 years: a population-based study.

Authors: P Mattsson; K Svärdsudd; P O Lundberg; C E Westerberg
Journal: Cephalalgia Date: 2000-12 Impact factor: 6.292

Review 5. Treating epilepsy in the elderly: safety considerations.

Authors: S Arroyo; G Kramer
Journal: Drug Saf Date: 2001 Impact factor: 5.606

6. Geriatric headache. How to make the diagnosis and manage the pain.

Authors: D M Biondi; J R Saper
Journal: Geriatrics Date: 2000-12

7. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist.

Authors: H Doods; G Hallermayer; D Wu; M Entzeroth; K Rudolf; W Engel; W Eberlein
Journal: Br J Pharmacol Date: 2000-02 Impact factor: 8.739

8. Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit.

Authors: Dianne Kirby; Susan Harrigan; David Ames
Journal: Int J Geriatr Psychiatry Date: 2002-03 Impact factor: 3.485

Review 9. Inappropriate medications for elderly patients.

Authors: Darryl S Chutka; Paul Y Takahashi; Robert W Hoel
Journal: Mayo Clin Proc Date: 2004-01 Impact factor: 7.616

10. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial.

Authors: Erling Tronvik; Lars J Stovner; Grethe Helde; Trond Sand; Gunnar Bovim
Journal: JAMA Date: 2003-01-01 Impact factor: 56.272

3 in total

Review 1. Episodic Migraine and Older Adults.

Authors: Nina Riggins; Annika Ehrlich
Journal: Curr Pain Headache Rep Date: 2022-04-06

2. Efficacy and Safety of Chuanxiong Qingnao Granule in Patients with Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors: Yi-Fan Li; Hui-Min Hu; Bo-Ning Wang; Yi Zhang; Xing Liu; Peng Mao; Bi-Fa Fan
Journal: Evid Based Complement Alternat Med Date: 2021-12-22 Impact factor: 2.629

3. Eptinezumab for migraine prevention in patients 50 years or older.

Authors: Vincent Martin; Cristina Tassorelli; Anders Ettrup; Joe Hirman; Roger Cady
Journal: Acta Neurol Scand Date: 2022-02-26 Impact factor: 3.915

3 in total